Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
What is the Immune System?01:38

What is the Immune System?

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Features and Outcome Measures Across Still Disease (Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still Disease) Cohorts Worldwide: A Systematic Literature Review.

The Journal of rheumatology·2026
Same author

Participant Attrition Associated With Longitudinal Use of Safety Flag Protocols in Adolescent Substance Use Research.

Substance use & addiction journal·2026
Same author

Sex Differences in PROMIS Pediatric Depressive Symptoms, Anxiety, and Psychological Stress Among Children and Adolescents Living With Pediatric Rheumatic Diseases.

The Journal of rheumatology·2026
Same author

Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group.

Seminars in arthritis and rheumatism·2025
Same author

Congruence Between Child Self-Reported and Caregiver-Proxy-Reported Health-Related Quality of Life in Children With Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus.

The Journal of rheumatology·2025
Same author

Barriers to Surgical Care in Craniofacial Scleroderma (Parry-Romberg Syndrome).

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association·2025

Related Experiment Video

Updated: Jun 21, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

Drug-induced autoimmunity.

Fatma Dedeoglu1

  • 1Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA. fatma.dedeoglu@childrens.harvard.edu

Current Opinion in Rheumatology
|July 14, 2009
PubMed
Summary
This summary is machine-generated.

Drug-induced autoimmunity (DIA) presents with a wider range of clinical features and autoantibody profiles. Research is ongoing to understand the complex mechanisms behind these medication-induced autoimmune responses.

More Related Videos

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Experiment Videos

Last Updated: Jun 21, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

  • Immunology
  • Pharmacology
  • Clinical Medicine

Background:

  • Drug-induced autoimmunity (DIA) is a recognized adverse drug reaction.
  • The spectrum of DIA has historically been characterized by specific clinical and autoantibody patterns.

Purpose of the Study:

  • To highlight the expanding spectrum of drug-induced autoimmunity (DIA) features.
  • To discuss novel clinical presentations and autoantibody profiles in DIA.
  • To address the potential for chronicity in DIA.

Main Methods:

  • This is a review article, synthesizing existing literature on DIA.
  • Analysis of recent findings on medication-induced autoimmune syndromes.
  • Examination of emerging autoantibody patterns and clinical manifestations.

Main Results:

  • The number of drugs associated with DIA has increased, alongside a broader range of clinical and autoantibody features.
  • Biologics and newer medications are associated with diverse signs, symptoms, and autoantibody profiles, including rashes and visceral involvement.
  • Shift observed from antihistone antibodies to anti-dsDNA antibodies in drug-induced lupus; some drugs may induce the condition they are intended to treat.

Conclusions:

  • Mechanisms underlying DIA remain incompletely understood despite its long-standing recognition.
  • Emerging data on novel DIA features are prompting new hypotheses and research directions.
  • Pharmacogenetics and pharmacogenomics are expected to enhance understanding of DIA and other drug adverse effects.